Significance of Interleukin-22 and CD38 in Chronic Lymphocytic Leukemia | ||||
| Minia Journal of Medical Research | ||||
| Article 59, Volume 30, Issue 4, October 2019, Page 365-371 PDF (303.74 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjmr.2022.221791 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Nancy A. Abdelhamed Youssef; Esmat A. Al-Sharkawy; Emad A. Abdelnaiem; Waleed M. Abdelhamed | ||||
| Department of Clinical Pathology, El-Minia Faculty of Medicine | ||||
| Abstract | ||||
| Chronic lymphocytic leukaemia (CLL) is a common type of leukaemia characterised by an abnormal increase in T-cell count. T-helper cytokines were reported to stimulate the survival and proliferation of CLL cells and could be correlated with disease progression. This study aims to study the possible inter-regulation and correlation between IL-22 and CD38 in CLL patients. It was carried out on newly diagnosed B-CLL patients and healthy controls. Routine laboratory investigations were carried out for all subjects. Haematological laboratory investigations were performed for all subjects, these included CD19, CD38 and interleukin-22 (IL-22) absolute and percentage counts. CLL patients showed a significant (P<0.05) increase in CD19, CD38 and IL- 22 absolute and percentage counts by comparison to the healthy control subjects. 25% of CLL patients showed positive CD38 expression. Interestingly, IL-22 percentages showed an association with CD38 expression. IL-22 percentage showed an increase in patients with high CD38 expression and a decrease in patients with low CD38 expression. Moreover, there was a significant (P<0.05) positive correlation between CD38 and IL-22 with Pearson’s correlation coefficient (r=0.621). Thus, CD38 and IL-22 could act in synergy to maintain CLL cell survival and proliferation and could be used as diagnostic and prognostic markers. | ||||
| Keywords | ||||
| Chronic lymphocytic leukaemia; Interleukin-22 (IL-22) and CD38 | ||||
|
Statistics Article View: 83 PDF Download: 108 |
||||
